For the genes in the first category (CDH2, CTNNA3, and TJP1) multicenter studies, some currently underway, will address whether the identification of segregating P/LP variants in ARVC families will be replicated and if so in what proportion of gene-elusive ARVC cases. This evidence concerns the gene CTNNA3 and arrhythmogenic right ventricular cardiomyopathy.